Drw Securities, LLC Novartis Ag Transaction History

Drw Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $641,324 - $743,859	-6,928 Reduced 14.95%	39,405 $4.2 Million
Q1 2024 May 14, 2024	BUY	$95.27 - $108.47 $3.56 Million - $4.05 Million	37,369 Added 416.88%	46,333 $4.48 Million
Q4 2023 Feb 16, 2024	BUY	$92.27 - $101.54 $365,666 - $402,403	3,963 Added 79.24%	8,964 $905,000
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $175,724 - $195,016	1,855 Added 58.96%	5,001 $509,000
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $85,025 - $96,412	919 Added 41.27%	3,146 $317,000
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $178,226 - $206,687	2,227 New	2,227 $205,000
Q1 2022 May 12, 2022	SELL	$80.11 - $90.62 $240,330 - $271,860	-3,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $239,100 - $264,390	3,000 New	3,000 $262,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.